Search - tctmd.com

Displaying 161 - 180 of 4204

Sort: Relevancy | Date

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Presentation TCT 2024

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

Presenter: Marco Ancona

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

TCT 917: Transcatheter Aortic Valve Implantation With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The International Multicenter NAVULTRA Registry

Presenter: Stefano Cannata

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

Presenter: Vincent Lipari

October 30, 2024

Presentation TCT 2024

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

Presenter: Mohammad Reza Movahed

October 30, 2024

Presentation TCT 2024

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

Presenter: Constantijn Venema

October 30, 2024

Presentation TCT 2024

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

Presenter: Rishi Sukhija

October 30, 2024

Presentation TCT 2024

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

Presenter: Rupak Banerjee

October 30, 2024

Presentation TCT 2024

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Presenter: Zaid Abdulelah

October 30, 2024

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

Presenter: Pierre Elias

October 30, 2024

Presentation TCT 2024

TCT 836: Laser Ablation: A Novel Approach to Mitigate Coronary Obstruction and Maintain Coronary Access in Transcatheter Aortic Valve Replacement Procedures

Presenter: Ali Azadani

October 30, 2024

Presentation TCT 2024

TCT 834: Percutaneous Coronary Interventions in Patients With Prior Transcatheter Aortic Valve Replacement

Presenter: Chloe Kharsa

October 30, 2024

Presentation TCT 2024

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

Presenter: Yair Feld

October 30, 2024

Presentation TCT 2024

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

Presenter: Junaid Mir

October 30, 2024

Advertisement

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

TCT 917: Transcatheter Aortic Valve Implantation With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The International Multicenter NAVULTRA Registry

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field?

TCT 836: Laser Ablation: A Novel Approach to Mitigate Coronary Obstruction and Maintain Coronary Access in Transcatheter Aortic Valve Replacement Procedures

TCT 834: Percutaneous Coronary Interventions in Patients With Prior Transcatheter Aortic Valve Replacement

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content